Asset Details
Do you wish to reserve the book?
Live vaccinations in dermatology for immunosuppressed patients: a narrative review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Live vaccinations in dermatology for immunosuppressed patients: a narrative review
Do you wish to request the book?
Live vaccinations in dermatology for immunosuppressed patients: a narrative review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Live vaccinations in dermatology for immunosuppressed patients: a narrative review
2024
Overview
Given the higher susceptibility to infectious disease in patients receiving immunosuppressive therapies for inflammatory dermatologic conditions, immunization is important in this population. While live vaccines protect against life-threatening diseases, they can be harmful in immunosuppressed patients given the risk of replication of the attenuated pathogen and adverse reactions. The utilization of live vaccines in immunosuppressed patients depends on multiple factors such as the vaccine and therapy regimen. To provide an overview of evidence-based recommendations for the use of live vaccines in patients receiving immunosuppressive therapies for dermatological conditions. A literature search of the PubMed database was performed using keywords
live vaccine
,
live-attenuated vaccine
,
dermatology
,
immunosuppressed
, and
immunocompromised
, and specific immunosuppressive therapies:
corticosteroids, glucocorticoids, methotrexate, azathioprine, cyclosporine, mycophenolate mofetil, biologics.
Relevant articles written in English were included. Using these keywords, 125 articles were reviewed, of which 28 were ultimately selected. Recommendations for live vaccines can be determined on a case-by-case basis. Measles, mumps, rubella, varicella (MMRV) vaccines may be safely administered to patients on low-dose immunosuppressive agents while the yellow fever vaccine is typically contraindicated. It may be safe to administer live MMRV boosters to children on immunosuppressive therapies and the live herpes zoster vaccine to patients on biologics. Given poor adherence to immunization guidelines in immunosuppressed patients, dermatologists have a critical role in educating patients and general practitioners regarding live vaccines. By reviewing a patient’s vaccination history and following immunization guidelines prior to initiating immunosuppressive therapies, physicians can mitigate morbidity and mortality from vaccine-preventable diseases.
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
Subject
/ Chickenpox Vaccine - administration & dosage
/ Chickenpox Vaccine - adverse effects
/ Disease
/ Eczema
/ Fever
/ Humans
/ Measles
/ Measles-Mumps-Rubella Vaccine - administration & dosage
/ Measles-Mumps-Rubella Vaccine - adverse effects
/ Medicine
/ Mumps
/ Patients
/ Review
/ Rubella
/ Smallpox
/ Steroids
/ Vaccination - adverse effects
/ Vaccines
/ Vaccines, Attenuated - administration & dosage
/ Vaccines, Attenuated - adverse effects
